The long-awaited vaccine is a necessary tool in the fight against the most common respiratory viruses.
angelp/iStock via Getty Images Plus
The newly approved RSV vaccine could be rolled out by fall 2023, in time for the typical winter surge in RSV infections.
In a matter of days, eligible people will be lining up to receive the newly formulated booster shot.
filadendron/E+ via Getty Images
The CDC’s endorsement of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.
As of August 2022, COVID-19 vaccination rates in Black and Hispanic people exceeded those of white Americans nationally, but only for the initial shots.
FatCamera/E+ via Getty Images
Early on, public health messaging focused on the need for vaccines to combat COVID-19. But far less attention has been given to the role of boosters in preventing deaths and reducing inequities.
We hear a lot about drug-resistant bacteria. The same thing can happen with viruses.
It’s natural to have questions about the risks and benefits of COVID vaccines in young children. Here’s what you need to know ahead of Australia’s rollout.
Is it time for a new generation of COVID vaccines? Here’s where the research is at.
Clinical studies show that mixing and matching booster vaccines can lead to a more robust immune response.
SDI Productions/E+ via Getty Images
On the horizon: A new omicron-focused version of the Moderna vaccine that may offer longer protection and a stronger immune response.
Global Justice campaigners in London stand by fake coffins to highlight global COVID-19 deaths. If pharma companies waived intellectual property rights, it would be easier for low- and middle-income countries to access COVID-19 vaccines.
(AP Photo/Alastair Grant)
Waiving patent rights on COVID-19 vaccines and drugs is still crucial to ensure access globally, but the waiver on the table at the June World Trade Organization meeting doesn’t do the job.
Boosters and vaccinating children mean we’re relying on two pharmaceutical companies to supply Australia’s COVID vaccines. That needs to change.
The COVID-19 pandemic has taught most people more than they ever expected to know about immunology.
Membio/iStock via Getty Images Plus
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
Fewer people reported needing to miss work after their booster, compared to their second dose.
Both companies say their drugs will work against the Omicron variant, though this is based on preliminary, lab-based research.
We’re reliant on overseas supply - and the many moving parts of delivery. Each of those parts require staff on the ground – and many workers in this system are likely being affected by Omicron.
The best way to stop new variants from arising is to increase the proportion of vaccinated individuals while maintaining infection prevention measures like wearing masks and social distancing.
Even with a variant like Omicron that may be more transmissible than earlier variants, vaccines remain the most effective tool for protection against COVID-19 and for ending the pandemic.
The Pfizer COVID-19 vaccine will be available for children aged 5-11 from January 10, after it cleared the final regulatory step. Here’s what you need to know.
What not to do: ban travel. Scenes at South Africa’s OR Tambo International airport after the first flight bans were announced.
Phill Magakoe / AFP via Getty Images
The world needs to learn to live with the virus. And governments must follow the science and don’t distort it for political expediency.
If authorized, molnupiravir could be a key oral treatment to help keep COVID-19 patients out of the hospital.
Plyushkin/iStock via Getty Images Plus
Merck and Pfizer both have oral antiviral pills under review by the FDA. Such treatments could help turn the tide of the pandemic.
The Lagos State government recently approved some private health facilities to administer COVID-19 vaccines in the state.
Olukayode Jaiyeola/NurPhoto via Getty Images
Properly engaged and monitored, Nigeria’s private sector can do more in COVID vaccination exercise.
Paxlovid is one potential COVID drug for use at home. The idea is these can potentially be prescribed at the first sign of infection to prevent serious illness and death.
People queuing to get vaccinated. Instead of vaccinating 12-17 year olds, government should focus on giving boosters to people who need it.
The focus of the government seems to be about how many people can get vaccinated rather than ensuring the greatest protection against severe disease and deaths.